A

Achieve Life Sciences

ACHV

4.78000
USD
-0.22
(-4.40%)
مغلق
حجم التداول
1,803
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
167,585,559
أصول ذات صلة
A
ADMA
-0.030
(-0.24%)
12.260 USD
A
ASRT
-0.02000
(-1.44%)
1.37000 USD
E
EVOK
4.38330
(1,077.77%)
4.79000 USD
M
MBRX
-0.85000
(-27.51%)
2.24000 USD
P
PIRS
0.480
(2.91%)
16.990 USD
V
VCEL
-2.900
(-5.72%)
47.800 USD
V
VKTX
-2.380
(-4.18%)
54.610 USD
V
VTVT
0.010
(0.07%)
14.540 USD
الأخبار المقالات

العنوان: Achieve Life Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.